Side-by-side comparison of AI visibility scores, market position, and capabilities
BrightInsight is the leading global regulated digital health platform for biopharma and medtech; raised $166M total (Series C $101M led by General Catalyst in 2021); supports SaMD, connected devices, and disease management programs.
BrightInsight is a digital health infrastructure company that provides the leading global regulated platform for biopharma and medtech companies building Software as a Medical Device (SaMD) and connected health programs. Founded in 2017 by Kal Patel, a former Bristol-Myers Squibb executive, BrightInsight is headquartered in San Jose, California. The company's platform captures, transmits, and analyzes data from FDA-regulated and CE-marked medical devices, combination products, digital therapeutics, and companion apps — all while maintaining compliance with HITRUST, GDPR, FDA 21 CFR Part 11, IEC 62304, and other regulatory frameworks. This regulated-by-design infrastructure layer eliminates the need for biopharma and medtech companies to build compliant digital health backends from scratch.
Doximity (NYSE: DOCS), professional network for US physicians with 2M+ verified clinicians; telehealth, medical news, and career tools monetized via pharmaceutical digital marketing.
Doximity is a professional network and digital health platform purpose-built for licensed physicians and other healthcare professionals in the United States. With more than two million verified clinicians on the platform — representing the majority of practicing US physicians — Doximity has established itself as the dominant professional network for doctors, providing identity-verified peer connections, specialty-specific news feeds, medical journal access, and career management tools including a physician job board and CV builder. The verification layer distinguishes Doximity from general professional networks and makes it the standard reference for confirming physician credentials and contact information across the healthcare industry.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.